Clinical trials showing the single-shot Janssen vaccine as being 66 percent effective at preventing the COVID-19 disease are “very encouraging,” British Prime Minister Boris Johnson said on Friday.
“We have secured 30 million doses, and if approved by our medicines regulator we should expect these to be available later this year,” he wrote on Twitter.
